Newport Trust Company
AGN

Newport Trust Company’s Allergan plc AGN Stock Holding History

Newport Trust Company’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,153,450
Closed -$204M – 49
2020
Q1 		$204M Sell
1,153,450
-57,913
-5% -$10.9M 0.84% 14
2019
Q4 		$232M Sell
1,211,363
-39,018
-3% -$7.04M 0.62% 18
2019
Q3 		$210M Sell
1,250,381
-18,721
-1% -$3.05M 0.56% 18
2019
Q2 		$212M Sell
1,269,102
-24,810
-2% -$3.44M 0.57% 17
2019
Q1 		$189M Buy
1,293,912
+8,613
+0.7% +$1.25M 0.57% 18
2018
Q4 		$172M Sell
1,285,299
-12,665
-1% -$2.08M 0.56% 19
2018
Q3 		$247M Sell
1,297,964
-24,645
-2% -$4.53M 0.69% 17
2018
Q2 		$221M Sell
1,322,609
-53,824
-4% -$8.64M 0.64% 18
2018
Q1 		$232M Buy
1,376,433
+4,409
+0.3% +$740K 0.65% 17
2017
Q4 		$224M Buy
+1,372,024
New +$246M 0.63% 21

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Newport Trust Company's AGN Position: Q2 2020 in Review

Newport Trust Company sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,153,450 shares — an estimated $204M sold.

Newport Trust Company first reported a position in AGN in Q4 2017 and held it in 10 quarters. The position peaked at $247M in Q3 2018. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Newport Trust Company reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Newport Trust Company sold 1,153,450 Allergan plc shares in Q2 2020, an estimated $204M.
  • Newport Trust Company first reported a position in Allergan plc in Q4 2017 and held it in 10 quarters.
  • Newport Trust Company's Allergan plc position peaked at $247M in Q3 2018.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Newport Trust Company's 13F filing for Q2 2020, filed 11 Aug 2020.